ecancermedicalscience

Review

Conducting Phase IV clinical studies: a moral imperative?

26 Oct 2012
TP Hill

The answer to this question lies in knowing the moral standing of Phase IV studies and whether we ought to conduct them. And to know this, in part, we need to compare them to studies in Phases I, II, and III and then determine where Phase IV studies stand in relation to Phase I–III studies scientifically and commercially.

Related Articles

Chalothorn Wannaphut, Phuuwadith Wattanachayakul, Sakditad Saowapa, Ben Ponvilawan, Manasawee Tanariyakul, Jakrin Kewcharoen, Pitchaporn Yingchoncharoen, Thanathip Suenghataiphorn, Noppawit Aiumtrakul, Jared Acoba
Fatuma Affey, Dabo Galgalo Halake, Grace Muira Wainaina, Hussein Ali Osman, James G Ndukui, Houda Abdourahman, Omar Abdihamid
José Richard Tenazoa-Villalobos, Edgar Fermín Yan-Quiroz, Augusto Ordoñez-Chinguel, Sofia Leonor Prado-Cucho, Adesman Isac Miranda-Narro, Vladimir Villoslada-Terrones
Jade Tso, Mustafa Al-Qaraghli, Susana Galeas, Mustafa Faleh Abidalhassan, Cameron E Gaskill
Samuel Santiago Parra Giraldo, Rut Amparo Vergara López, Haydee De La Hoz-Herazo, Enrique Carlos Ruiz Pla, Brayan Bayona-Pacheco, Juan Jose Espitia De La Hoz